7Baggers

GH Stock Income Statements

The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
     Revenue  
     Gross Profit  
     Operating Profit  
     Net Income  
    Quarterly
     | 
    Annual
     
    20190630 20190930 20191231 20200331 20200630 20200930 20201231 20210331 20210630 20210930 20211231 20220331 20220630 20220930 20221231 20230331 20230630 20230930 20231231 20240331 -229.43-172.59-115.74-58.89-2.0554.8111.64168.49Milllion
    Quarterly Income Statements
    Quarterly
     | 
    Annual
     
      Unit: USD2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 
                               
        revenue:                       
        precision oncology testing156,229,000 142,189,000 133,423,000 125,244,000 113,393,000 113,797,000 102,054,000 92,062,000 84,136,000 88,707,000 79,272,000 72,604,000 63,729,000 64,703,000 60,384,000 50,991,000 60,246,000 57,414,000 52,147,000 42,064,000 28,837,000 28,096,000 18,298,000 
        development services and other12,262,000 12,865,000 9,607,000 11,906,000 15,321,000 13,094,000 15,350,000 17,082,000 11,963,000 19,401,000 15,507,000 19,497,000 14,936,000 13,613,000 14,185,000         
        total revenue168,491,000 155,054,000 143,030,000 137,150,000 128,714,000 126,891,000 117,404,000 109,144,000 96,099,000 108,108,000 94,779,000 92,101,000 78,665,000 78,316,000 74,569,000 66,335,000 67,510,000 62,897,000 60,848,000 53,975,000 36,655,000 32,873,000 21,692,000 
        yoy30.90% 22.19% 21.83% 25.66% 33.94% 17.37% 23.87% 18.50% 22.16% 38.04% 27.10% 38.84% 16.52% 24.51% 22.55% 22.90% 84.18% 91.33% 180.51%     
        qoq8.67% 8.41% 4.29% 6.55% 1.44% 8.08% 7.57% 13.57% -11.11% 14.06% 2.91% 17.08% 0.45% 5.02% 12.41% -1.74% 7.33% 3.37% 12.73% 47.25% 11.50% 51.54%  
        costs and operating expenses:                       
        cost of precision oncology testing59,306,000 57,417,000 53,648,000 49,357,000 45,106,000 43,706,000 39,434,000 34,375,000 30,684,000 32,254,000 29,665,000 24,887,000 23,590,000 22,070,000 16,699,000 17,809,000 18,191,000 20,004,000 16,578,000 14,650,000 11,023,000 12,624,000 9,671,000 
        cost of development services and other5,990,000 5,100,000 3,966,000 4,491,000 7,967,000 3,415,000 1,062,000 2,352,000 1,297,000 1,168,000 1,151,000 5,040,000 5,157,000 6,337,000 4,488,000         
        research and development expense83,802,000 89,856,000 93,851,000 90,359,000 93,128,000 106,578,000 100,017,000 85,455,000 81,757,000 73,021,000 70,968,000 63,724,000 55,508,000 40,282,000 36,245,000 36,319,000 37,016,000 25,875,000 24,569,000 19,532,000 16,316,000 16,652,000 14,253,000 
        sales and marketing expense80,425,000 79,127,000 68,934,000 71,043,000 76,123,000 81,423,000 80,370,000 73,603,000 64,432,000 59,599,000 50,228,000 47,716,000 34,338,000 31,288,000 25,095,000 25,015,000 25,115,000 22,287,000 18,802,000 19,439,000 17,807,000 17,114,000 13,464,000 
        general and administrative expense38,651,000 37,665,000 36,174,000 41,516,000 40,445,000 37,888,000 41,121,000 43,680,000 41,267,000 40,274,000 50,055,000 48,376,000 67,935,000 69,505,000 66,294,000 37,186,000 19,785,000 18,859,000 16,440,000 13,439,000 12,661,000 12,547,000 8,129,000 
        total costs and operating expenses268,174,000 352,565,000 256,573,000 256,766,000 262,769,000 273,010,000 262,004,000 239,465,000 219,437,000 206,316,000 202,067,000 189,743,000 186,528,000 169,482,000 148,821,000 120,955,000 102,422,000 88,859,000 78,325,000 69,243,000 60,319,000 60,260,000 45,897,000 
        income from operations-99,683,000 -197,511,000 -113,543,000 -119,616,000 -134,055,000 -146,119,000 -144,600,000 -130,321,000 -123,338,000 -98,208,000 -107,288,000 -97,642,000 -107,863,000 -91,166,000 -74,252,000 -54,620,000 -34,912,000 -25,962,000 -17,477,000 -15,268,000 -23,664,000 -27,387,000 -24,205,000 
        yoy-25.64% 35.17% -21.48% -8.21% 8.69% 48.79% 34.78% 33.47% 14.35% 7.72% 44.49% 78.77% 208.96% 251.15% 324.86% 257.74% 47.53% -5.20% -27.80%     
        qoq-49.53% 73.95% -5.08% -10.77% -8.26% 1.05% 10.96% 5.66% 25.59% -8.46% 9.88% -9.48% 18.31% 22.78% 35.94% 56.45% 34.47% 48.55% 14.47% -35.48% -13.59% 13.15%  
        interest income14,868,000 13,888,000 11,690,000 6,727,000 3,060,000 2,150,000 1,754,000 1,387,000 778,000 653,000 689,000 1,037,000 1,551,000 1,900,000 2,313,000 2,640,000 3,318,000 3,871,000 4,286,000 3,099,000 2,485,000 2,334,000 958,000 
        interest expense-645,000 -645,000 -644,000 -645,000 -644,000 -644,000 -644,000 -645,000 -644,000 -643,000 -644,000 -644,000 -646,000 -4,736,000 -8,000 -10,000 -12,000 -321,000 -280,000 -287,000 -293,000 -299,000 -304,000 
        other income-29,120,000 -3,316,000 16,885,000 41,259,000 -1,654,000 5,281,000 -18,389,000 378,000 -48,000 25,898,000 -187,000 -243,000 -290,000 1,220,000 345,000 2,285,000 -209,000 -187,000 179,000 -51,000 147,000 115,000 43,000 
        income before benefit from income taxes-114,580,000 -187,584,000 -85,612,000 -72,275,000 -133,293,000 -139,332,000 -161,879,000 -228,986,000 -123,252,000 -72,300,000 -107,430,000 -97,492,000 -107,248,000 -92,782,000 -71,602,000 -49,705,000 -31,815,000 -22,599,000 -13,292,000 -12,507,000 -21,325,000 -25,237,000 -23,508,000 
        benefit from income taxes405,000 -541,000 490,000 496,000 240,000 602,000 115,000 446,000 -24,000 11,000 96,000 83,000 110,000 263,000 68,000 34,000 14,000 -489,000 -202,000 -1,207,000 26,000 35,000  
        net income-114,985,000 -187,043,000 -86,102,000 -72,771,000 -133,533,000 -139,934,000 -161,994,000 -229,432,000 -123,228,000 -72,311,000 -107,526,000 -97,575,000 -107,358,000 -93,045,000 -71,670,000 -49,739,000 -31,829,000 -22,110,000 -13,090,000 -11,300,000 -21,351,000 -25,272,000 -23,508,000 
        yoy-13.89% 33.67% -46.85% -68.28% 8.36% 93.52% 50.66% 135.13% 14.78% -22.28% 50.03% 96.17% 237.30% 320.83% 447.52% 340.17% 49.07% -12.51% -44.32%     
        qoq-38.52% 117.23% 18.32% -45.50% -4.57% -13.62% -29.39% 86.18% 70.41% -32.75% 10.20% -9.11% 15.38% 29.82% 44.09% 56.27% 43.96% 68.91% 15.84% -47.08% -15.52% 7.50%  
        net income per share-0.94 -1.62 -0.73 -0.67 -1.3 -1.37 -1.58 -2.25 -1.21 -0.89 -1.06 -0.96 -1.09 -0.94 -0.78 -0.57 -0.29 -0.28 -0.14 -0.13 -0.3 2.07 -1.94 
        weighted-average shares used for eps calculation121,712 111,988 117,736 108,808 102,663 102,178 102,289 102,047 101,853 101,314 101,420 101,172 100,955 97,504 99,554 96,011 94,382 90,597 93,303 89,036 85,935 30,403 12,582 
        fair value adjustments of noncontrolling interest liability       -99,785,000                
        adjustment of redeemable noncontrolling interest         -18,600,000   -2,300,000 -700,000 -6,000,000 -4,900,000 4,100,000       
        net income attributable to guardant health, inc. common stockholders     -139,934,000 -161,994,000 -229,432,000 -123,228,000 -90,911,000 -107,526,000 -97,575,000 -109,658,000 -93,745,000 -77,670,000 -54,639,000 -27,729,000 -25,210,000 -12,790,000 -11,600,000 -26,051,000 -25,122,000 -24,458,000